21:11 , Jun 4, 2019 |  BC Extra  |  Financial News

June 4 Financial Quick Takes: Lung Therapeutics' $36M series C; plus Strand, Hansoh, Inhibrx and more

Lung Therapeutics closes $36M series C  Lung Therapeutics Inc. (Austin, Texas) raised $36 million in a series C round led by Bios Partners with participation by undisclosed new and existing investors. Lung has raised $53...
18:57 , Apr 25, 2019 |  BC Extra  |  Financial News

Gritstone raises $75M in follow-on as second neoantigen immunotherapy heads to clinic

Days after saying it plans to accelerate its second neoantigen immunotherapy into the clinic, Gritstone has raised $74.8 million in a follow-on. Gritstone Oncology Inc. (NASDAQ:GRTS) sold $6.5 million shares at $11.50 in the deal,...
19:34 , Apr 4, 2019 |  BC Extra  |  Financial News

Follow-on roundup: Sangamo, Tricida, DBV

Sangamo and Tricida each priced follow-ons soon after their share prices spiked on recent clinical readouts. DBV also raised a follow-on ahead of a planned BLA resubmission. Sangamo Therapeutics Inc. (NASDAQ:SGMO) raised $126.5 million on...
22:53 , Mar 27, 2019 |  BC Extra  |  Financial News

With $126M IPO, Precision aims to bring allogeneic CAR T to clinic this half

Precision raised $126.4 million Wednesday in a NASDAQ IPO that values the gene editing company at about $784.5 million. Precision BioSciences Inc. (NASDAQ:DTIL) sold 7.9 million shares at $16, the midpoint of its proposed range....
13:47 , Mar 27, 2019 |  BC Extra  |  Financial News

NASH company Genfit gains dual listing via NASDAQ offering

Liver disease company Genfit gained $1.85 to $22.17 on Wednesday after the company raised a combined $135.1 million via a NASDAQ offering and concurrent private placement. In the NASDAQ offering, Genfit S.A. (Euronext:GNFT; NASDAQ:GNFT) raised...
16:38 , Mar 22, 2019 |  BC Week In Review  |  Financial News

Precision sets terms for IPO

Precision set a price range for its proposed NASDAQ IPO on Monday, planning to sell 7.9 million shares between $15-$17. At the midpoint of the proposed range, Precision BioSciences Inc. (Durham, N.C.) would raise $126.4...
17:33 , Mar 8, 2019 |  BC Week In Review  |  Financial News

Genome editing company Precision proposes $100M IPO

With plans to bring an allogeneic CAR T immunotherapy into the clinic, Precision BioSciences Inc. (Durham, N.C.) proposed March 1 to raise up to $100 million in an IPO on NASDAQ. Precision plans to start...
00:53 , Mar 2, 2019 |  BC Extra  |  Financial News

Genome editing company Precision proposes $100M IPO

With plans to bring an allogeneic CAR T immunotherapy into the clinic, Precision BioSciences Inc. (Durham, N.C.) proposed Friday to raise up to $100 million in an IPO on NASDAQ. Precision plans to start this...
20:09 , Mar 1, 2019 |  BC Week In Review  |  Financial News

Genfit files for NASDAQ listing

France’s Genfit S.A. (Euronext:GNFT) proposed a NASDAQ offering that would give the company a dual listing. The company, whose lead molecule elafibranor is in Phase III testing to treat non-alcoholic steatohepatitis (NASH), proposed to raise...
05:48 , Feb 28, 2019 |  BC Extra  |  Financial News

Genfit files for NASDAQ listing

France’s Genfit S.A. (Euronext:GNFT) proposed a NASDAQ offering that would give the company a dual listing. The company, whose lead molecule elafibranor is in Phase III testing to treat non-alcoholic steatohepatitis (NASH), proposed to raise...